Drug Reaction
7
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
29%
2 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis
Motion Sickness Medications and Vestibular Time Constant
An Evaluation of Healthcare Providers' Adherence to Pharmacovigilance Practices in an African Community
Pharmacogenetics Study on the Effects of Anesthetic Drugs on Circulatory Function
Schistosomiasis Diagnosis Using a CAA Antigen Test
Evaluation of Efficacy and Safety of Subcutaneous Acetaminophen
Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)